| __timestamp | CRISPR Therapeutics AG | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 2917513 |
| Thursday, January 1, 2015 | 13403000 | 7878291 |
| Friday, January 1, 2016 | 31056000 | 8366794 |
| Sunday, January 1, 2017 | 35845000 | 6610381 |
| Monday, January 1, 2018 | 48294000 | 6556000 |
| Tuesday, January 1, 2019 | 63488000 | 6930000 |
| Wednesday, January 1, 2020 | 88208000 | 8758000 |
| Friday, January 1, 2021 | 102802000 | 10806000 |
| Saturday, January 1, 2022 | 102464000 | 9844000 |
| Sunday, January 1, 2023 | 76162000 | 13481000 |
| Monday, January 1, 2024 | 72977000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. CRISPR Therapeutics AG and Soleno Therapeutics, Inc. offer a fascinating comparison. Over the past decade, CRISPR Therapeutics has seen its SG&A expenses grow significantly, peaking in 2021 with a 1,700% increase from 2014. In contrast, Soleno Therapeutics has maintained a more stable trajectory, with expenses increasing by approximately 360% over the same period.
CRISPR's aggressive expansion strategy is evident in its rising costs, reflecting its commitment to innovation and market penetration. Meanwhile, Soleno's steadier approach suggests a focus on sustainable growth. As of 2023, CRISPR's expenses have slightly decreased, indicating a potential shift towards cost optimization. Investors and industry watchers should consider these trends when evaluating the financial strategies of these biotech players.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and CRISPR Therapeutics AG
Breaking Down SG&A Expenses: Zoetis Inc. vs CRISPR Therapeutics AG
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Soleno Therapeutics, Inc. Trends and Insights
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared